Literature DB >> 30721332

[Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges].

C Karagiannidis1, T Bein2, S Weber-Carstens3.   

Abstract

The present work sheds light on the possibilities and limitations of modern extracorporeal membrane oxygenation (ECMO) therapy in the case of heart or lung failure. Since the number of applications of extracorporeal lung and heart/lung replacement procedures has increased dramatically in the last few years in severely ill patients, decision-making for a meaningful indication and in the course of a possible therapy target change has become particularly difficult, especially with regard to the complex situation in organ transplantation in Germany. An attempt is made to elucidate the dilemma between data from large controlled trials and epidemiological studies and the patients' individuality.

Entities:  

Keywords:  Critical illness; Epidemiology; Ethics; Heart failure; Terminal care

Mesh:

Year:  2019        PMID: 30721332     DOI: 10.1007/s00063-019-0533-3

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  23 in total

1.  Extracorporeal life support, ethics, and questions at the bedside: how does the end of the pathway look?

Authors:  Thomas Bein; Steffen Weber-Carstens; Margaret Herridge
Journal:  Intensive Care Med       Date:  2015-02-25       Impact factor: 17.440

2.  Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011.

Authors:  Christopher M Sauer; David D Yuh; Pramod Bonde
Journal:  ASAIO J       Date:  2015 Jan-Feb       Impact factor: 2.872

3.  Extracorporeal membrane oxygenation: evolving epidemiology and mortality.

Authors:  Christian Karagiannidis; Daniel Brodie; Stephan Strassmann; Erich Stoelben; Alois Philipp; Thomas Bein; Thomas Müller; Wolfram Windisch
Journal:  Intensive Care Med       Date:  2016-03-04       Impact factor: 17.440

4.  Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control.

Authors:  Lorenzo Del Sorbo; Lara Pisani; Claudia Filippini; Vito Fanelli; Luca Fasano; Pierpaolo Terragni; Andrea Dell'Amore; Rosario Urbino; Luciana Mascia; Andrea Evangelista; Camillo Antro; Raffaele D'Amato; Maria José Sucre; Umberto Simonetti; Pietro Persico; Stefano Nava; V Marco Ranieri
Journal:  Crit Care Med       Date:  2015-01       Impact factor: 7.598

5.  Invasive home mechanical ventilation: living conditions and health-related quality of life.

Authors:  Sophie Emilia Huttmann; Wolfram Windisch; Jan Hendrik Storre
Journal:  Respiration       Date:  2015-03-19       Impact factor: 3.580

6.  Understanding the treatment preferences of seriously ill patients.

Authors:  Terri R Fried; Elizabeth H Bradley; Virginia R Towle; Heather Allore
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

7.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

Review 8.  Extracorporeal resuscitation for refractory out-of-hospital cardiac arrest in adults: A systematic review of international practices and outcomes.

Authors:  Iván Ortega-Deballon; Laura Hornby; Sam D Shemie; Farhan Bhanji; Elena Guadagno
Journal:  Resuscitation       Date:  2016-02-01       Impact factor: 5.262

9.  Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study.

Authors:  Thomas Bein; Steffen Weber-Carstens; Anton Goldmann; Thomas Müller; Thomas Staudinger; Jörg Brederlau; Ralf Muellenbach; Rolf Dembinski; Bernhard M Graf; Marlene Wewalka; Alois Philipp; Klaus-Dieter Wernecke; Matthias Lubnow; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2013-01-10       Impact factor: 17.440

10.  Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations.

Authors:  Christian Karagiannidis; Kristin Aufm Kampe; Fernando Suarez Sipmann; Anders Larsson; Goran Hedenstierna; Wolfram Windisch; Thomas Mueller
Journal:  Crit Care       Date:  2014-06-17       Impact factor: 9.097

View more
  1 in total

1.  Feasibility, safety, and resource utilisation of active mobilisation of patients on extracorporeal life support: a prospective observational study.

Authors:  Stephan Braune; Patrick Bojes; Anne Mecklenburg; Federico Angriman; Gerold Soeffker; Katja Warnke; Dirk Westermann; Stefan Blankenberg; Mathias Kubik; Hermann Reichenspurner; Stefan Kluge
Journal:  Ann Intensive Care       Date:  2020-12-01       Impact factor: 6.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.